We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
CYP3A5 Genotype, but Not CYP3A4*1b, CYP3A4*22, or Hematocrit, Predicts Tacrolimus Dose Requirements in Brazilian Renal Transplant Patients.
- Authors
Santoro, A B; Struchiner, C J; Felipe, C R; Tedesco‐Silva, H; Medina‐Pestana, J O; Suarez‐Kurtz, G
- Abstract
A letters to the editor is presented in response to articles "In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients" by de Jonge and colleagues in the previous issue.
- Subjects
TACROLIMUS; HEMATOCRIT; TRANSPLANTATION of organs, tissues, etc.; PATIENTS
- Publication
Clinical Pharmacology & Therapeutics, 2013, Vol 94, Issue 2, p201
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1038/clpt.2013.68